(KO) The Coca-Cola - NYSE
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NYSE (USA) | Market Cap: 341.574m USD | Total Return: 17.3% in 12m
Avg Turnover: 1.36B
EPS Trend: 99.0%
Qual. Beats: 4
Rev. Trend: 95.9%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
The Coca-Cola Company (NYSE: KO) is a global nonalcoholic beverage manufacturer founded in 1886 and headquartered in Atlanta, Georgia. It produces and sells a broad portfolio of drinks including sparkling soft drinks, water, sports drinks, coffee, tea, juices, value-added dairy, plant-based beverages, and emerging beverage categories. Its brand portfolio spans flagship labels such as Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Sprite, and Fanta, alongside water brands like Dasani, smartwater, and Topo Chico, as well as coffee, juice, and dairy offerings including Costa, Minute Maid, and fairlife.
In addition to finished beverages, the company sells beverage concentrates, syrups, and fountain syrups to retailers such as restaurants and convenience stores. Distribution is handled through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as company-operated bottling and distribution assets.
The company operates within the Consumer Staples sector and is classified in the Soft Drinks & Non-alcoholic Beverages sub-industry. Its business model is anchored by the traditional concentrate-based system, in which Coca-Cola manufactures and sells syrups and concentrates to bottling partners that handle packaging, distribution, and local market execution-an asset-light structure that supports global scale while limiting direct capital exposure to bottling operations.
- Emerging markets revenue lifts results amid developed market softness
- Pricing actions offset NARTY concentrate volume declines
- fairlife and BODYARMOR accelerate premium portfolio growth
| Net Income: 13.7b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 12.97 > 1.0 |
| NWC/Revenue: 16.26% < 20% (prev 5.05%; Δ 11.20% < -1%) |
| CFO/TA 0.14 > 3% & CFO 14.6b > Net Income 13.7b |
| Net Debt (34.1b) to EBITDA (19.2b): 1.77 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.31b) vs 12m ago 0.02% < -2% |
| Gross Margin: 61.74% > 18% (prev 61.07%; Δ 0.67% > 0.5%) |
| Asset Turnover: 47.86% > 50% (prev 46.10%; Δ 1.77% > 0%) |
| Interest Coverage Ratio: 11.08 > 6 (EBIT TTM 18.2b / Interest Expense TTM 1.64b) |
| A: 0.08 (Total Current Assets 30.4b - Total Current Liabilities 22.4b) / Total Assets 104b |
| B: 0.79 (Retained Earnings 82.0b / Total Assets 104b) |
| C: 0.18 (EBIT TTM 18.2b / Avg Total Assets 103b) |
| D: 0.49 (Book Value of Equity 33.6b / Total Liabilities 68.5b) |
| Altman-Z'' = 4.77 = AA |
| DSRI: 0.85 (Receivables 3.67b/4.09b, Revenue 49.3b/46.9b) |
| GMI: 0.99 (GM 61.07% / 61.74%) |
| AQI: 0.96 (AQ_t 0.62 / AQ_t-1 0.64) |
| SGI: 1.05 (Revenue 49.3b / 46.9b) |
| TATA: -0.01 (NI 13.7b - CFO 14.6b) / TA 104b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of June 23, 2026, the stock is trading at USD 79.53 with a total of 21,187,486 shares traded. Over the past week, the price has changed by -3.12%, over one month by -1.76%, over three months by +6.57% and over the past year by +17.27%.
Current recommended Stop Loss: 77.20 (which is 2.9% or 1.5 ATR below the current price).
The Coca-Cola has received a consensus analysts rating of 4.35. Therefore, it is recommended to buy KO.
- StrongBuy: 14
- Buy: 8
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 86 | 8.1% |
P/E Trailing = 24.9654
P/E Forward = 24.5098
P/S = 6.9307
P/B = 10.225
P/EG = 4.0864
Revenue TTM = 49.3b USD
EBIT TTM = 18.2b USD
EBITDA TTM = 19.2b USD
Long Term Debt = 39.1b USD (from longTermDebt, last quarter)
Short Term Debt = 4.83b USD (from shortTermDebt, last quarter)
Debt = 45.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 34.1b USD (calculated: Debt 45.2b - CCE 11.1b)
Enterprise Value = 376b USD (342b + Debt 45.2b - CCE 11.1b)
Interest Coverage Ratio = 11.08 (Ebit TTM 18.2b / Interest Expense TTM 1.64b)
EV/FCF = 29.91x (Enterprise Value 376b / FCF TTM 12.6b)
FCF Yield = 3.34% (FCF TTM 12.6b / Enterprise Value 376b)
FCF Margin = 25.49% (FCF TTM 12.6b / Revenue TTM 49.3b)
Net Margin = 27.80% (Net Income TTM 13.7b / Revenue TTM 49.3b)
Gross Margin = 61.74% ((Revenue TTM 49.3b - Cost of Revenue TTM 18.9b) / Revenue TTM)
Gross Margin QoQ = 62.96% (prev 60.05%)
Tobins Q-Ratio = 3.61 (Enterprise Value 376b / Total Assets 104b)
Interest Expense / Debt = 3.63% (Interest Expense 1.64b / Debt 45.2b)
Taxrate = 16.82% (2.78b / 16.6b)
NOPAT = 15.1b (EBIT 18.2b * (1 - 16.82%))
Current Ratio = 1.36 (Total Current Assets 30.4b / Total Current Liabilities 22.4b)
Debt / Equity = 1.34 (Debt 45.2b / totalStockholderEquity, last quarter 33.6b)
Debt / EBITDA = 1.77 (Net Debt 34.1b / EBITDA 19.2b)
Debt / FCF = 2.72 (Net Debt 34.1b / FCF TTM 12.6b)
Total Stockholder Equity = 31.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.31% (Net Income 13.7b / Total Assets 104b)
RoE = 43.62% (Net Income TTM 13.7b / Total Stockholder Equity 31.4b)
RoCE = 25.82% (EBIT 18.2b / Capital Employed (Equity 31.4b + L.T.Debt 39.1b))
RoIC = 17.97% (NOPAT 15.1b / Invested Capital 84.2b)
WACC = 4.78% (E(342b)/V(387b) * Re(5.01%) + D(45.2b)/V(387b) * Rd(3.63%) * (1-Tc(0.17)))
Discount Rate = 5.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.86 | Cagr: -0.16%
[DCF] Terminal Value 75.44% ; FCFF base≈12.6b ; Y1≈12.6b ; Y5≈13.4b
[DCF] Fair Price = 40.37 (EV 208b - Net Debt 34.1b = Equity 174b / Shares 4.30b; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 99.04 | EPS CAGR: 6.22% | SUE: 4.0 | # QB: 4
Revenue Correlation: 95.89 | Revenue CAGR: 3.14% | SUE: 0.63 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.93 | Chg30d=+0.24% | Revisions=-58% | Analysts=17
EPS next Quarter (2026-09-30): EPS=0.88 | Chg30d=-0.06% | Revisions=+50% | Analysts=17
EPS current Year (2026-12-31): EPS=3.27 | Chg30d=+0.04% | Revisions=+83% | GrowthEPS=+8.9% | GrowthRev=+2.1%
EPS next Year (2027-12-31): EPS=3.48 | Chg30d=-0.00% | Revisions=+58% | GrowthEPS=+6.6% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: +83%